Plaque Psoriasis Latest Advances

Risankizumab super responders in moderate-to-severe psoriasis: prevalence, predictors, and long-term maintenance in a multicenter, international, real-world cohort.

Journal: The Journal of dermatological treatment

Published: January 23, 2026

Icotrokinra: A Promising Oral IL-23 Receptor Inhibitor for Moderate-to-Severe Plaque Psoriasis.

Journal: Skin therapy letter

Published: January 20, 2026

Impact of secukinumab with modified nourishing blood and moisturising decoction on superficial fungal infections in patients with psoriasis with blood-dryness pattern.

Journal: Journal of wound care

Published: January 13, 2026

Persistence of interleukin-17 and interleukin-23 inhibitors in patients with plaque psoriasis: a real-world study in Taiwan.

Journal: The Journal of dermatological treatment

Published: January 12, 2026

Do Nails Tell a Pulmonary Tale? A Cross-Sectional Study on Psoriasis and Pulmonary Hypertension Risk.

Journal: Journal of cutaneous medicine and surgery

Published: January 12, 2026

Efficacy and safety of cannabidiol oil in psoriasis: a randomized, double-blind, placebo-controlled trial.

Journal: The Journal of dermatological treatment

Published: December 29, 2025

IL-17 Class Inhibitors and Plaque Psoriasis: Not All Biologics Relapse Equally.

Journal: The Journal of clinical and aesthetic dermatology

Published: December 19, 2025

Predominance of Palmoplantar Psoriasis in Inuit Patients from Ungava Bay, Nunavik.

Journal: Journal of cutaneous medicine and surgery

Published: December 18, 2025

Tildrakizumab in real-world Chinese psoriasis: efficacy-safety profiles from a 28-week retrospective cohort with geriatric, late-onset and metabolic syndrome stratification.

Journal: The Journal of dermatological treatment

Published: December 16, 2025

Laboratory monitoring in patients with moderate to severe plaque psoriasis.

Journal: The Journal of dermatological treatment

Published: December 05, 2025

Response to "Reevaluating Fire Needle Therapy in Mild Plaque Psoriasis: Clinical Relevance and Methodological Considerations".

Journal: QJM : monthly journal of the Association of Physicians

Published: December 05, 2025

Evaluation of the Therapeutic and Economic Impact of Adalimumab Versus Methotrexate in the Management of Psoriasis: A Prospective Comparative Study.

Journal: Cureus

Published: December 03, 2025